GeoPolitics Pulse

The Heartbeat of World events

European Commission approves Celltrion’s SteQeyma ® (CT-P43), a biosimilar to Stelara …

by ·

Celltrion today announced that the European Commission (EC) has approved the use of SteQeyma® (CT-P43), an ustekinumab biosimilar referencing …Read More

Related posts:

  1. European Commission approves Celltrion’s SteQeyma® (CT-P43), a biosimilar to Stelara …
  2. European Commission approves aflibercept biosimilar OPUVIZ (previously SB15) from …
  3. European Commission Approves Biocon Biologics’ Ustekinumab Biosimilar
  4. Celltrion Expands Biosimilar Portfolio in the European Union Following European … – Business Wire
  5. Bevacizumab Biosimilar Receives Approval in the European Union – OncLive